Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

In Vitro Comparison of Different TKI Activity in T-Cell Populations: Selective Sparing of Treg By Nilotinib

Elena Marinelli Busilacchi, ScD, Andrea Costantini, MD, Nadia Viola, ScD, Benedetta Costantini, MD, Antonella Poloni, MD, Jacopo Olivieri, MD, Francesco Saraceni, MD, Giorgia Mancini, MD, Attilio Olivieri, MD

Blood (2016) 128 (22): 5774.

https://doi.org/10.1182/blood.V128.22.5774.5774

Published: 2016

Journal Articles

The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib

Elena Marinelli Busilacchi, ScD, Jacopo Olivieri, MD, Nadia Viola, ScD, Antonella Poloni, MD, Giorgia Mancini, MD, Francesco Saraceni, MD, Anna Campanati, MD, Gaia Goteri, MD, Silvia Svegliati, ScD, Armando Gabrielli, MD, Attilio Olivieri, MD

Blood (2016) 128 (22): 4597.

https://doi.org/10.1182/blood.V128.22.4597.4597

Published: 2016

Journal Articles

Post Induction WT1 MRD Analysis Significantly Predicts Early Relapse in Acute Myeloid Leukemia (AML) Patients

Debora Capelli, MD, Imma Attolico, MD, Giorgia Mancini, MD, Stefania Mancini, Francesco Saraceni, MD, Nadia Viola, Anna Rita Scortechini, MD, Pasquina Pascale, MD, Ilaria Scortechini, MD, Pietro Leoni, Prof, Attilio Olivieri, Prof

Blood (2015) 126 (23): 4976.

https://doi.org/10.1182/blood.V126.23.4976.4976

Published: 2015

Journal Articles

Nilotinib For Steroid-Refractory Chronic Graft Versus Host Disease (SR-cGVHD): Preliminary Results Of a Phase I-II GITMO Study (Gruppo Italiano Trapianto di Midollo Osseo)

Attilio Olivieri, Prof., Michele Cimminiello, MD, PhD, Ivana Latesoriere, Pietro Leoni, Francesco Onida, MD, Roberta Fedele, MD, Paolo Corradini, Vincenzo Pavone, Roberta Nuccorini, Sara Pasquina Pascale, Jacopo Olivieri, Giorgia Mancini, MD, Sonia Mammoliti, Alessandro Rambaldi, MD

Blood (2013) 122 (21): 4608.

https://doi.org/10.1182/blood.V122.21.4608.4608

Published: 2013

Journal Articles

Geriatric Assessment Driven Treatment In 149 AML Elderly Patients

Debora Capelli, MD, Francesco Saraceni, MD, Martina Chiarucci, MD, Antonella Poloni, Giorgia Mancini, MD, Silvia Trappolini, MD, Massimo Offidani, MD, Serena Rupoli, MD, Mauro Montanari, MD, Anna Rita Scortechini, MD, Guido Gini, MD, Ilaria Scortechini, MD, Giancarlo Discepoli, MD, Pietro Leoni, Prof., Attilio Olivieri, Prof.

Blood (2013) 122 (21): 3943.

https://doi.org/10.1182/blood.V122.21.3943.3943

Published: 2013

NARROW

In Vitro Comparison of Different TKI Activity in T-Cell Populations: Selective Sparing of Treg By Nilotinib

The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib

Post Induction WT1 MRD Analysis Significantly Predicts Early Relapse in Acute Myeloid Leukemia (AML) Patients

Nilotinib For Steroid-Refractory Chronic Graft Versus Host Disease (SR-cGVHD): Preliminary Results Of a Phase I-II GITMO Study (Gruppo Italiano Trapianto di Midollo Osseo)

Geriatric Assessment Driven Treatment In 149 AML Elderly Patients

Email alerts

ASH Publications

American Society of Hematology

In Vitro Comparison of Different TKI Activity in T-Cell Populations: Selective Sparing of Treg By Nilotinib

The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib

Post Induction WT1 MRD Analysis Significantly Predicts Early Relapse in Acute Myeloid Leukemia (AML) Patients

Nilotinib For Steroid-Refractory Chronic Graft Versus Host Disease (SR-cGVHD): Preliminary Results Of a Phase I-II GITMO Study (Gruppo Italiano Trapianto di Midollo Osseo)

Geriatric Assessment Driven Treatment In 149 AML Elderly Patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only